4//SEC Filing
DWEK RAYMOND 4
Accession 0001415889-24-020750
CIK 0001082554other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:30 PM ET
Size
17.8 KB
Accession
0001415889-24-020750
Insider Transaction Report
Form 4
DWEK RAYMOND
Director
Transactions
- Sale
Common Stock
2024-08-02$320.39/sh−900$288,349→ 5,850 total - Exercise/Conversion
Stock Options
2024-08-02−5,000→ 10,000 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (5,000 underlying) - Sale
Common Stock
2024-08-02$321.29/sh−900$289,158→ 4,950 total - Sale
Common Stock
2024-08-02$330.39/sh−100$33,039→ 1,750 total - Sale
Common Stock
2024-08-02$326.40/sh−900$293,757→ 4,050 total - Exercise/Conversion
Common Stock
2024-08-02$175.43/sh+5,000$877,150→ 6,750 total - Sale
Common Stock
2024-08-02$327.95/sh−1,300$426,342→ 2,750 total - Sale
Common Stock
2024-08-02$328.99/sh−900$296,089→ 1,850 total
Footnotes (5)
- [F1]This transaction was executed in multiple trades at prices ranging from $320.04 to $320.8924. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $321.14 to $321.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $325.98 to $326.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $327.505 to $328.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $328.54 to $329.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001231617
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:30 PM ET
- Size
- 17.8 KB